Casdin Capital, LLC - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 39 filers reported holding LIANBIO in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$307,558
-34.6%
206,4150.0%0.03%
-17.1%
Q2 2023$470,626
+16.9%
206,4150.0%0.04%
+24.2%
Q1 2023$402,509
+18.9%
206,4150.0%0.03%
+26.9%
Q4 2022$338,521
-17.6%
206,4150.0%0.03%
-3.7%
Q3 2022$411,000
-7.8%
206,4150.0%0.03%
-28.9%
Q2 2022$446,000
-41.8%
206,4150.0%0.04%
+11.8%
Q1 2022$766,000
-39.8%
206,4150.0%0.03%
-5.6%
Q4 2021$1,272,000206,4150.04%
Other shareholders
LIANBIO shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$4,472,8856.12%
Perceptive Advisors 57,558,451$112,814,5633.33%
SCHF (GPE), LLC 937,500$1,8383.24%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,303,573$6,475,0030.65%
Cormorant Asset Management, LP 4,250,000$8,3300.55%
Affinity Asset Advisors, LLC 650,000$1,267,5000.42%
22NW, LP 141,223$276,7970.17%
MYDA Advisors LLC 120,000$235,2000.09%
Logos Global Management LP 280,000$548,8000.08%
TANG CAPITAL MANAGEMENT LLC 209,600$410,8160.06%
View complete list of LIANBIO shareholders